HomeCompareVPTDF vs PLD

VPTDF vs PLD: Dividend Comparison 2026

VPTDF yields 2312.14% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPTDF wins by $38613850930.11M in total portfolio value
10 years
VPTDF
VPTDF
● Live price
2312.14%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38613850936.61M
Annual income
$35,586,201,922,515,856.00
Full VPTDF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — VPTDF vs PLD

📍 VPTDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPTDFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPTDF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VPTDF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPTDF
Annual income on $10K today (after 15% tax)
$196,531.79/yr
After 10yr DRIP, annual income (after tax)
$30,248,271,634,138,476.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, VPTDF beats the other by $30,248,271,629,670,504.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPTDF + PLD for your $10,000?

VPTDF: 50%PLD: 50%
100% PLD50/50100% VPTDF
Portfolio after 10yr
$19306925471.56M
Annual income
$17,793,100,963,886,146.00/yr
Blended yield
92.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

VPTDF
No analyst data
Altman Z
-272.5
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPTDF buys
0
PLD buys
0
No recent congressional trades found for VPTDF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPTDFPLD
Forward yield2312.14%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$38613850936.61M$6.50M
Annual income after 10y$35,586,201,922,515,856.00$5,256,436.18
Total dividends collected$38401207511.77M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VPTDF vs PLD ($10,000, DRIP)

YearVPTDF PortfolioVPTDF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$241,914$231,213.87$11,255$555.24+$230.7KVPTDF
2$5,486,310$5,227,462.00$13,062$1,018.59+$5.47MVPTDF
3$116,667,010$110,796,658.85$15,903$1,926.67+$116.65MVPTDF
4$2,326,799,779$2,201,966,078.24$20,839$3,823.32+$2326.78MVPTDF
5$43,532,552,320$41,042,876,556.38$30,464$8,166.08+$43532.52MVPTDF
6$764,223,950,336$717,644,119,353.02$52,054$19,457.30+$764223.90MVPTDF
7$12,591,932,032,884$11,774,212,406,024.32$109,886$54,188.93+$12591931.92MVPTDF
8$194,782,556,253,371$181,309,188,978,186.10$304,030$186,451.18+$194782555.95MVPTDF
9$2,829,578,517,848,077$2,621,161,182,656,969.50$1,166,125$840,813.32+$2829578516.68MVPTDF
10$38,613,850,936,613,300$35,586,201,922,515,856.00$6,504,190$5,256,436.18+$38613850930.11MVPTDF

VPTDF vs PLD: Complete Analysis 2026

VPTDFStock

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

Full VPTDF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this VPTDF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPTDF vs SCHDVPTDF vs JEPIVPTDF vs OVPTDF vs KOVPTDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.